(Total Views: 597)
Posted On: 06/05/2020 8:00:55 PM
Post# of 145248
![Avatar](https://investorshangout.com/images/ProfileImages/259520172_62777_mark2.jpg)
Re: reallypeople? #36836
Calquence (acalabrutinib) is a kinase inhibitor indicated for the treatment of adult patients with mantle cell lymphoma (MCL) who have received at least one prior therapy.
Common side effects of Calquence include:
anemia,
low platelet count (thrombocytopenia),
headache,
low white blood cell count (neutropenia),
diarrhea,
fatigue,
muscle pain,
bruising,
nausea,
abdominal pain,
constipation,
vomiting,
rash,
and nosebleed.
Common side effects of Calquence include:
anemia,
low platelet count (thrombocytopenia),
headache,
low white blood cell count (neutropenia),
diarrhea,
fatigue,
muscle pain,
bruising,
nausea,
abdominal pain,
constipation,
vomiting,
rash,
and nosebleed.
![](/m/images/thumb-up.png)
![](/m/images/thumb-down.png)
Whatever happens, we have got
Le-Ron-Li-Mab, and they have not.
Le-Ron-Li-Mab, and they have not.